Docoh
Loading...

CC Chemours

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

April 28, 2020

Date of Report (Date of Earliest Event Reported)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-36794

 

46-4845564

(State or Other Jurisdiction

 

(Commission

 

(I.R.S. Employer

Of Incorporation)

 

File Number)

 

Identification No.)

 

1007 Market Street

Wilmington, Delaware, 19801

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (302) 773-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Exchange on Which Registered

Common Stock ($.01 par value)

 

CC

 

New York Stock Exchange

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 


 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The Chemours Company (the “Company”) held its annual meeting of shareholders on April 28, 2020 (the “Annual Meeting”).

 

At the Annual Meeting, shareholders:

 

 

elected all nine director nominees to serve a one-year term;

 

approved the Company’s annual “say-on-pay” vote on an advisory basis;

 

ratified PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2020; and

 

voted against the shareholder proposal.

 

The final voting results for each proposal were as follows:

 

Proposal 1 – Election of Directors to Serve One-Year Term

Nominee

For

Against

Abstain

Total

Broker Non-Votes

Curtis V. Anastasio

115,011,915

(99.21%)

   686,897

232,944

115,931,756

27,709,175

Bradley J. Bell

114,615,168

(98.86%)

1,082,595

233,993

115,931,756

27,709,175

Richard H. Brown

114,724,801

(98.96%)

   982,581

224,373

115,931,755

27,709,176

Mary B. Cranston

114,574,816

(98.83%)

1,136,231

220,709

115,931,756

27,709,175

Curtis J. Crawford

114,122,805

(98.44%)

1,585,300

223,648

115,931,753

27,709,178

Dawn L. Farrell

114,639,856

(98.89%)

1,065,847

226,052

115,931,755

27,709,176

Erin N. Kane

114,720,121

(98.96%)

   993,965

217,669

115,931,755

27,709,176

Sean D. Keohane

114,705,616

(98.94%)

1,003,865

222,269

115,931,750

27,709,181

Mark P. Vergnano

115,075,817

(99.26%)

   647,411

208,525

115,931,753

27,709,178

 

Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation

For

Against

Abstain

Total

Broker Non-Votes

109,513,548

(94.46%)

5,829,514

588,686

115,931,748

27,709,183

 

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm

For

Against

Abstain

Total

Broker Non-Votes

142,171,502

(98.98%)

1,057,598

411,831

143,640,931

n/a

 

Proposal 4 – Shareholder Proposal for a Board Advisory Position

For

Against

Abstain

Total

Broker Non-Votes

4,043,867

(3.49%)

111,144,957

742,915

115,931,739

27,709,192

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

THE CHEMOURS COMPANY

 

By:

 

/s/ Sameer Ralhan

 

 

Sameer Ralhan

 

 

Senior Vice President, Chief Financial

 

 

Officer and Treasurer

 

Date:

 

April 29, 2020